Cellyan Biotechnology Co., Ltd

Cellyan Biotechnology Co., Ltd

HKPD - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.39M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cellyan Biotechnology Co., LtdCellyan Biotechnology Co., Ltd-3.7--12%0.10.1
$1.22

Current Fair Value

8.3% downside

Overvalued by 8.3% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2.39 Million
Enterprise Value$3.43 Million
Earnings per Share$-0.97
Beta2.23
Outstanding Shares1,800,000

Return

Return on Equity-12.14%ROE
Return on Assets-9.05%
Return on Invested Capital-8.44%

Valuation & Multiples

P/E Ratio-3.68P/E Ratio
PEG-7.26PEG
Price to Sales0.07Price to Sales
Price to Book Ratio0.27Price to Book Ratio
Enterprise Value to Revenue0.1
Enterprise Value to EBIT-4.21
Enterprise Value to Net Income-3
Total Debt to Enterprise0.37
Debt to Equity0.13Debt to Equity

Revenue Sources

No data

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %1.34%▲ 0.66%
Total Invested$54,383▼ 48.59%
Investors Holding4▼ 2.00%

About Cellyan Biotechnology Co., Ltd

27 employees
CEO: Chenyu Liang

Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the internati...